Wall Street give IsoRay Medical’s (AMEX:ISR) shares a beating today after the company announced that it had sold about $14.7 million in common stock to a pair of unnamed institutional investors.
Funding Roundup
Presbia files for $90M IPO
Presbia, which makes the Flexiview Micro-Lens corneal implant to treat presbyopia, registered with the SEC for an initial public offering of up to $90 million worth of stock.
The Flexiview Micro-Lens is designed to be inserted into a pocket created in the cornea using a laser. The pocket seals itself, holding the 3mm-diameter lens in the center of the visual axis. The 10-minute procedure is reversible and does not require general anesthesia, according to Presbia’s website.
Google Glass startup gains funding for flagship product | Medtech funding stories for the week of Mar. 17, 2014
Euro VC Ysios Capital seeks $134M for lifesciences fund
European venture capital firm Ysios Capital is looking to raise some $137.8 million (€100 million) in support of its lifesciences investment activities.
Ysios plans to use funds from the investment pool, which the company calls its BioFund II, to support up to 15 lifesciences companies with disruptive potential. The company in 2008 raised about $95 million (€69 million) for its BioFund I, according to a press release.
NinePoint Medical lands $34M for high-res organ imaging
Massachusetts-based NinePoint Medical Imaging closed a $34 million Series B funding round, the company announced today.
NinePoint plans to use the funds to support ongoing U.S. commercial efforts for its NvisionVLE system, which provides high-res, endoscopic imaging of organs and tissues. The system can provide cross-sectional, volumetric views of organs, including tissues below the surface, the company said.
Zimmer, Draeger and Altitude tally $234M in Pentagon supply deals
A trio of medical device makers collected Pentagon supply deals worth a collective $234.3 million, according to recent Defense Dept. reports.
Augmedix raises $3.2M for Google Glass for docs
Augmedix calls itself the "first and largest Google Glass startup poised to revolutionize healthcare," touting a $3.2 million venture funding round and a move to a larger headquarters in San Francisco.
Oculeve raises $16.6M in support of dry eye disease treatment
San Francisco startup Oculeve Inc. closed a $16.6 million funding round in supports of its implantable technology for treatment of dry eye disease.
OnTarget Labs lands $15M for tumor fluorescing tech
OnTarget Laboratories said it landed a $15 million investment from a pair of backers for its tumor-lighting technology developed at Purdue University by the founder of Endocyte (NSDQ:ECYT).
Catheter maker Bi02 Medical raises $6M
Bi02 Medical, maker of the Angel vena cava filter catheter, said it raised nearly $5.9 million in a hoped-for $7.5 million equity offering.
The funding round for the San Antonio, Texas-based medical device company involved 10 unnamed investors, according to a regulatory filing.
Spinal firm K2M aims for $100M IPO
Spinal surgery devices maker K2M Group Holdings hopes to raise as much as $100 million through its impending initial public offering, according to registration documents filed with the SEC.